| Name | Title | Contact Details |
|---|
Independent Beachbody Coach is a Wilsonville, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Karma Medical Products De is a Portsmouth, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Valley Medical Center (VMC), also known as King County Public Hospital District No. 1, is located in Renton, WA. The Medical Center’s service area includes the communities of Renton, Kent, Tukwila, Covington, Maple Valley, Auburn, Newcastle and the surrounding environs. A 303-bed acute care hospital and clinic network, VMC is committed to providing safe, quality compassionate care and has done so for more than 63 years. Seattle magazine named VMC the #1 non-profit in the state for 2011, the Puget Sound Business Journal honored VMC as “Washington’s Best Workplace” for 2011 in the extra large company category, and for ten consecutive years VMC has been named a “Best Workplace” by regional publications. For the past four out of four years VMC has been named a “Best Place to Work in Healthcare” in the nation by Modern Healthcare magazine, including twice achieving a top 10 ranking. Valley Medical Center is a component entity of UW Medicine.
Our vision is to serve our communities’ evolving healthcare needs by cultivating a network of compassionate, dedicated professionals. We are committed to working together, using best practices, improving quality, and assuring an exceptional patient experience. Our highest priority is caring for people - the friends, family and neighbors whom we serve in our community. We are committed to providing an environment based on respect and one which encourages personal and profession growth.
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.